These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15283135)

  • 21. Targeting transcription factors for cancer therapy.
    Frank DA
    IDrugs; 2009 Jan; 12(1):29-33. PubMed ID: 19127502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in tumor vasculature targeting using liposomal drug delivery systems.
    Abu Lila AS; Ishida T; Kiwada H
    Expert Opin Drug Deliv; 2009 Dec; 6(12):1297-309. PubMed ID: 19780711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [International estimation of molecular target drug].
    Fujisaka Y; Saijo N
    Nihon Rinsho; 2004 Jul; 62(7):1225-31. PubMed ID: 15283137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of pro-drug therapy in the treatment of cancer.
    Ferguson MJ; Ahmed FY; Cassidy J
    Drug Resist Updat; 2001 Aug; 4(4):225-32. PubMed ID: 11991677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer chemopreventive agents-drugs for the 21st century?
    Baer-Dubowska W
    Acta Pol Pharm; 2006; 63(5):369-73. PubMed ID: 17357586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current and future drugs targeting one class of innate immunity receptors: the Toll-like receptors.
    Romagne F
    Drug Discov Today; 2007 Jan; 12(1-2):80-7. PubMed ID: 17198976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new probe for targeting drug delivery system.
    Yu Z; Wang B; Sui J; Feng Y; Zheng C
    Med Hypotheses; 2009 Jan; 72(1):43-4. PubMed ID: 18829175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New targets and challenges in the molecular therapeutics of cancer.
    Eastman A; Perez RP
    Br J Clin Pharmacol; 2006 Jul; 62(1):5-14. PubMed ID: 16842374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status and future of target-based therapeutics.
    Suzuki R; Rao P; Sasaguri S
    Curr Cancer Drug Targets; 2007 May; 7(3):273-84. PubMed ID: 17504124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Targeting molecular mechanisms for cancer therapy].
    Takimoto R; Niitsu Y
    Nihon Rinsho; 2004 Jul; 62(7):1216-20. PubMed ID: 15283136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Approaches for targeting mitochondria in cancer therapy.
    D'Souza GG; Wagle MA; Saxena V; Shah A
    Biochim Biophys Acta; 2011 Jun; 1807(6):689-96. PubMed ID: 20732297
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solute carriers as drug targets: current use, clinical trials and prospective.
    Rask-Andersen M; Masuram S; Fredriksson R; Schiöth HB
    Mol Aspects Med; 2013; 34(2-3):702-10. PubMed ID: 23506903
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the exploration of anticancer targets and strategies in enhancing the efficacy of drug targeting.
    Zhu F; Zheng CJ; Han LY; Xie B; Jia J; Liu X; Tammi MT; Yang SY; Wei YQ; Chen YZ
    Curr Mol Pharmacol; 2008 Nov; 1(3):213-32. PubMed ID: 20021435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting cell migration protein could slow cancer cells spreading.
    Parks L
    Future Med Chem; 2013 Feb; 5(2):122. PubMed ID: 23476966
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular targeted drugs are too simple for common cancers, says UK researcher.
    Coombes R
    BMJ; 2010 Jan; 340():c153. PubMed ID: 20064848
    [No Abstract]   [Full Text] [Related]  

  • 36. [Molecular target therapy in cancer].
    Saijo N
    Nihon Rinsho; 2010 Oct; 68(10):1779-86. PubMed ID: 20954318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of molecular-target based drug].
    Sone S; Kakiuchi S; Yano S
    Nihon Rinsho; 2004 Jul; 62(7):1232-40. PubMed ID: 15283138
    [No Abstract]   [Full Text] [Related]  

  • 38. Co-targeting cancer drug escape pathways confers clinical advantage for multi-target anticancer drugs.
    Tao L; Zhu F; Xu F; Chen Z; Jiang YY; Chen YZ
    Pharmacol Res; 2015 Dec; 102():123-31. PubMed ID: 26438971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of molecular targeted anticancer agents: successes, failures and future directions.
    Chen EX; Siu LL
    Curr Pharm Des; 2005; 11(2):265-72. PubMed ID: 15638762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Future of chemotherapy].
    Grimm MO; Hartmann FH; Ackermann R
    Urologe A; 2006 May; 45(5):567-71. PubMed ID: 16710676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.